Hugues Bedouelle

USPTO Granted Patents = 7 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

where one patent can have more than one assignee

Years Active: 2007-2019

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10227385 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2019-03-12),

2. 9579375 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2017-02-28),

3. 8853379 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2014-10-07),

4. 8357496 - Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications (2013-01-22),

5. 8337857 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2012-12-25),

6. 7700303 - Biosensors, method for obtaining the same and uses thereof (2010-04-20),

7. 7271249 - Biosensors, method for obtaining the same and uses thereof (2007-09-18),

Title: Hugues Bedouelle: Innovator in Chimeric Polypeptides

Introduction

Hugues Bedouelle is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric polypeptides. With a total of 7 patents to his name, Bedouelle's work has the potential to impact therapeutic approaches against viral infections.

Latest Patents

One of Bedouelle's latest patents focuses on chimeric polypeptides and their therapeutic use against Flaviviridae infections. This invention relates to the construction of a chimeric polypeptide that can be utilized for the prevention or treatment of such infections. Additionally, the patent discloses the use of this innovative chimeric polypeptide for producing recombinant viral vectors, including a live measles viral vector.

Career Highlights

Throughout his career, Hugues Bedouelle has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of viral infections and developing new therapeutic strategies.

Collaborations

Bedouelle has collaborated with notable colleagues in his field, including Philippe Despres and Frederic Tangy. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Hugues Bedouelle's work in the realm of chimeric polypeptides showcases his dedication to advancing medical science. His inventions hold promise for improving treatment options for viral infections, marking him as a significant figure in biotechnology.

This text is generated by artificial intelligence and may not be accurate.